MedTech Strategist Issue: Vol. 5, No. 7 - May 29, 2018
Already a Subscriber?
Not a Subscriber?
Perspective Article: "Funding Gap? What Funding Gap?"
Few issues are as pressing as the role that strategics are playing and will play in funding medtech start-ups, especially as more traditional venture investors have retrenched and/or shifted to later-stage investments. Today, small medtechs look to strategics to move in as early-stage investors. That’s the flip side of the current biotech climate, where start-ups can be selective in their choice of investors and thus don’t depend on strategics to play any special role.
"Solving the Prisoner’s Dilemma: Product Innovation, Solutions-Focused Business Models Can Help Counter Declining Medtech ROC"
By Yakir Siegal, Glenn Snyder, Myriam Lopez, and Lauren Morton
Return on Capital performance for healthcare product manufacturers has been steadily declining. While medtech companies typically attempt to counter ROC declines with cost-savings initiatives, they may achieve more substantial, long-term value by boosting innovation and shifting toward a business model focused on transformational products and solutions that create step-change customer value.
Stroke Devices: "Neurovascular Device Market Poised for Growth"
By Oded Ben-Joseph and Seth Bensussen, Contributing Writers
Next-generation mechanical thrombectomy devices will be the chief driver of growth in the neurovascular device market. New clinical data suggesting that interventional treatment even up to 24 hours after stroke onset is beneficial for some patients could almost triple the number of patients eligible for treatment.
Market Disruptors: "Is Amazon’s Healthcare Foray a Threat to the Medtech Market?"
While it’s very early to assess the impact of Amazon’s entry into healthcare on the medical device industry, Wall Street analysts note that the most attractive subsectors have barriers to entry that will prove challenging to the digital retail giant.
Neuromodulation: "Saluda Medical: Will Sensors and Data Disrupt Spinal Cord Stimulation?"
With sensors that measure the response of nerves to stimulation and algorithms that adjust each pulse of a neurostimulation device to keep it in a therapeutic range, Saluda Medical sees early signs that it can boost the efficacy of spinal cord stimulation for pain and other neuromodulation therapies.
Start-Ups To Watch - "CroiValve: Solution for Tricuspid Regurgitation Supports the Native Valve
Each year, 550,000 new patients develop tricuspid regurgitation, a progressive condition in which the atrioventricular valve in the right side of the heart fails. Only 1% of TR patients can undergo surgery, and they face high surgical mortality rates. Early-stage CroiValve aims to offer cardiologists one device that can treat the majority of patients, in a simple, quick, nonsurgical procedure.
Start-Ups To Watch: "ChromaCode: Disrupting Molecular Diagnostics in the Digital Age"
By integrating chemical reactions and digital processing, ChromaCode has created a lower cost package of tools for expanding the multiplexing capabilities of existing PCR systems in a segment of the molecular world that is not well served by current technologies.
Not a Subscriber?
Already a Subscriber?
Want a Sample Article?
Companies Covered in this Issue: Abbott Laboratories Inc., Amazon.com Inc., bioMerieux SA, Boston Scientific Corp., Cardinal Health Inc., Cepheid, CroiValve, ChromaCode Inc., Cochlear Ltd., Edwards Lifesciences Corp., GenMark Diagnostics Inc., Illumina Inc., Intuitive Surgical Inc., Johnson & Johnson, Luminex Corp., Medina Medical, Medtronic PLC, Merck & Co. Inc., Nevro Corp., Nfocus Neuromedical, Penumbra Inc., Saluda Medical Pty. Ltd., Stryker Corp., Teleflex Inc., Terumo Corp., Thermo Fisher Scientific Inc.
Topics Covered in this Issue: Cardiovascular/Vascular, Diagnostics, Health Information Technology/Digital Health, Healthcare Delivery/Providers/Payors, Investment/Finance/M&As, Medtech Business Strategies/Development, Neurology/Neurovascular, Neurostimulation/Neuromodulation, Pain Management, Perspective/Commentary, Start-Ups, Surgery/Minimally Invasive Surgery, Robotics, Start-Ups